
The guidance outlines a commitment from the centre to encourage innovation, develop trusted approval systems and create a new pathway for innovators to sell into the health service.
Put simply, the code aims to ensure that the benefits of partnerships between tech companies and the health and care system are "shared fairly", providing "a basis to deepen the trust" between citizens, clinicians and the wider service, according to the DHSC - but this idea has long been mentioned by experts drawing attention to the potential and value of NHS data.
If you have been following the evolution of some of the companies that have been arguably more successful in transacting with the NHS, then this comes as no surprise to you.
""I think we can be the exemplar company on how we should innovate and then give back to the NHS"
Ross Upton, Ultromics
Several companies have already adopted this approach
When announcing the results of the first phase of their research partnership with Moorfields Eye Hospital NHS Foundation Trust, showing that the AI system developed could identify eye disease from OCT scans with 94% accuracy, DeepMind Co-Founder Mustafa Suleyman said that, if validated for general use by clinical trials, Moorfields would be able to use the system for free across 30 of their UK hospitals and community clinics for an initial period of five years.
Meanwhile, Oxford University spin-out Ultromics set up a clinical trial through its partnership with Oxford University across six NHS hospitals for what the company describes as the "world's most accurate" echocardiography software, soon to be extended to 20 NHS sites and a further 10 afterwards. Ultromics CEO and Co-Founder Ross Upton said that, once they receive regulatory clearance, NHS hospitals would be able to use the software "at no cost" under the initial clinical trial agreement.
"I think we can be the exemplar company on how we should innovate and then give back to the NHS," Upton told MobiHealthNews.
Code of conduct to become 'collaboratively agreed standard' in December
- Simplify the regulatory and funding landscape
- Create an environment to enable "experimentation"
- Accelerate and encourage uptake of innovation
- Improve interoperability and openness
- Engage users.
Twitter: @1Leontina
Contact the author: lpostelnicu@himss.org